苏州唯思尔康科技有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics 2024-04-10 21:15
Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation 2024-01-29 21:30
Exosomes functionally deliver siRNAs in vivo to repress tumor growth 2023-09-05 21:20
1